Biogen Inc.BIIBNASDAQ
Loading
Book Value/Share Growth Under PressureDecelerating
Percentile Rank28
3Y CAGR-65.9%
5Y CAGR-33.2%
Year-over-Year Change
Year-over-year book value per share growth
3Y CAGR
-65.9%/yr
vs -22.7%/yr prior
5Y CAGR
-33.2%/yr
Recent deceleration
Acceleration
-43.1pp
Decelerating
Percentile
P28
Within normal range
vs 5Y Ago
0.1x
Contraction
Streak
2 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q4 2025 | 0.20% |
| Q3 2025 | 2.76% |
| Q2 2025 | 3.86% |
| Q1 2025 | 1.43% |
| Q4 2024 | 2.18% |
| Q3 2024 | 2.89% |
| Q2 2024 | 4.16% |
| Q1 2024 | 2.58% |
| Q4 2023 | 2.14% |
| Q3 2023 | 0.06% |
| Q2 2023 | 4.67% |
| Q1 2023 | 2.76% |
| Q4 2022 | 5.09% |
| Q3 2022 | 8.73% |
| Q2 2022 | 6.60% |
| Q1 2022 | 2.24% |
| Q4 2021 | 1.47% |
| Q3 2021 | -1.86% |
| Q2 2021 | 6.72% |
| Q1 2021 | 0.97% |
| Q4 2020 | 1.53% |
| Q3 2020 | -2.58% |
| Q2 2020 | -3.11% |
| Q1 2020 | -3.29% |
| Q4 2019 | -1.34% |
| Q3 2019 | 11.75% |
| Q2 2019 | -3.22% |
| Q1 2019 | 7.79% |
| Q4 2018 | -4.53% |
| Q3 2018 | 15.47% |
| Q2 2018 | -10.89% |
| Q1 2018 | 11.48% |
| Q4 2017 | -2.00% |
| Q3 2017 | 11.28% |
| Q2 2017 | 2.69% |
| Q1 2017 | -5.01% |
| Q4 2016 | 1.18% |
| Q3 2016 | 6.33% |
| Q2 2016 | 10.31% |
| Q1 2016 | 10.92% |